Document Detail

Dyclonine rescues frataxin deficiency in animal models and buccal cells of patients with Friedreich's ataxia.
MedLine Citation:
PMID:  25113747     Owner:  NLM     Status:  In-Data-Review    
Inherited deficiency in the mitochondrial protein frataxin (FXN) causes the rare disease Friedreich's ataxia (FA), for which there is no successful treatment. We identified a redox deficiency in FA cells and used this to model the disease. We screened a 1600-compound library to identify existing drugs, which could be of therapeutic benefit. We identified the topical anesthetic dyclonine as protective. Dyclonine increased FXN transcript and FXN protein dose-dependently in FA cells and brains of animal models. Dyclonine also rescued FXN-dependent enzyme deficiencies in the iron-sulfur enzymes, aconitase and succinate dehydrogenase. Dyclonine induces the Nrf2 [nuclear factor (erythroid-derived 2)-like 2] transcription factor, which we show binds an upstream response element in the FXN locus. Additionally, dyclonine also inhibited the activity of histone methyltransferase G9a, known to methylate histone H3K9 to silence FA chromatin. Chronic dosing in a FA mouse model prevented a performance decline in balance beam studies. A human clinical proof-of-concept study was completed in eight FA patients dosed twice daily using a 1% dyclonine rinse for 1 week. Six of the eight patients showed an increase in buccal cell FXN levels, and fold induction was significantly correlated with disease severity. Dyclonine represents a novel therapeutic strategy that can potentially be repurposed for the treatment of FA.
Sunil Sahdeo; Brian D Scott; Marissa Z McMackin; Mittal Jasoliya; Brandon Brown; Heike Wulff; Susan L Perlman; Mark A Pook; Gino A Cortopassi
Related Documents :
23486667 - Innate cellular responses to rotavirus infection.
23220607 - Toll recognition signal activates oenocytoid cell lysis via a crosstalk between plasmat...
23074017 - Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old ...
25091807 - 3,4,5-trihydroxycinnamic acid increases heme-oxygenase-1 (ho-1) and decreases macrophag...
15890617 - Reactive oxygen species and the modulation of stroke.
18239127 - Cathepsin k-dependent toll-like receptor 9 signaling revealed in experimental arthritis.
Publication Detail:
Type:  Journal Article     Date:  2014-08-11
Journal Detail:
Title:  Human molecular genetics     Volume:  23     ISSN:  1460-2083     ISO Abbreviation:  Hum. Mol. Genet.     Publication Date:  2014 Dec 
Date Detail:
Created Date:  2014-11-27     Completed Date:  -     Revised Date:  2014-12-02    
Medline Journal Info:
Nlm Unique ID:  9208958     Medline TA:  Hum Mol Genet     Country:  England    
Other Details:
Languages:  eng     Pagination:  6848-62     Citation Subset:  IM    
Copyright Information:
© The Author 2014. Published by Oxford University Press.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A murine model of Neurofibromatosis Type 2 that accurately phenocopies human schwannoma formation.
Next Document:  An ALS-mutant TDP-43 neurotoxic peptide adopts an anti-parallel ?-structure and induces TDP-43 redis...